Evidence map›Paper›PMID 27582692›Full record

ReviewFrontiers in neural circuits2016

Interneuron Progenitor Transplantation to Treat CNS Dysfunction.

Muhammad O Chohan, Holly Moore

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neural circuits, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Direct reprogramming into interneurons: potential for brain repair.Cellular and molecular life sciences : CMLS · 2019
    Review
  7. CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  8. Opportunities and challenges in psychopharmacology
.Dialogues in clinical neuroscience · 2019
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Muhammad O ChohanDepartment of Integrative Neuroscience, New York State Psychiatric Institute, New YorkNY, USA; Department of Psychiatry, Columbia University, New YorkNY, USA.
Holly MooreDepartment of Integrative Neuroscience, New York State Psychiatric Institute, New YorkNY, USA; Department of Psychiatry, Columbia University, New YorkNY, USA.
Columbia University · USNew York Psychoanalytic Society and Institute · US

Funding

The Regulation of MGE Proliferation and Cortical Interneuron Fate DeterminationP01NS048120 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSS, MARGARET ELIZABETH · 2006 to 2015
$12.9M
NINDS NIH HHS P01 NS048120
6 · The paper itself

Abstract

Due to the inadequacy of endogenous repair mechanisms diseases of the nervous system remain a major challenge to scientists and clinicians. Stem cell based therapy is an exciting and viable strategy that has been shown to ameliorate or even reverse symptoms of CNS dysfunction in preclinical animal models. Of particular importance has been the use of GABAergic interneuron progenitors as a therapeutic strategy. Born in the neurogenic niches of the ventral telencephalon, interneuron progenitors retain their unique capacity to disperse, integrate and induce plasticity in adult host circuitries following transplantation. Here we discuss the potential of interneuron based transplantation strategies as it relates to CNS disease therapeutics. We also discuss mechanisms underlying their therapeutic efficacy and some of the challenges that face the field.

Indexed as

AnimalsCentral Nervous System DiseasesGABAergic NeuronsInterneuronsNeural Stem CellsStem Cell Transplantationexcitation-inhibitionGABAmedial ganglionic eminenceneuropsychiatric disordersstem cell therapy

Identifiers

PMID27582692
PMCPMC4987325
OpenAlexW2507312329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.